Background: The Drug Evaluation and Classification (DEC) program was developed to detect, arrest, and convict drivers impaired by drugs other than alcohol. The DEC program is a training program designed to prepare police officers and other qualified persons to serve as Drug Recognition Experts (DREs).
Purpose: The purposes of this study were: (1) to determine normative values and ranges for pupillary responses using the specific DEC program protocols for pupil testing in nonimpaired persons, and (2) to appraise the suitability of the 3.0- mm to 6.5-mm pupil range as a potential sign of impairment under three conditions.
Methods: Trained DRE officers measured pupi sizes using standardized DEC protocols. Pupil measurements were taken under three light levels: room light, near-total darkness, and direct light. The subjects were 250 volunteers, with an average age of 29.2 years (+/-6.1). All subjects were healthy, nonimpaired, and free of visual, and/or neurological problems.
Results: For each pupil measured (N= 500), the mean (SD) for each of the three test conditions were: room light 3.86 (0.93) mm; near-total darkness 6.41(1.55) mm; and direct light 3.35 (0.72) mm.
Conclusions: This study determined normative values and potential ranges for pupillary responses using the specific DEC program protocols for pupil testing in non-impaired persons. When the presently approved DEC program pupil size range (3.0 to 6.5 mm) is compared with the results of this study, it appears that the DEC range for pupil size might be too sensitive. However, when determining impairment related to drug(s), the DRE reviews the results of all tests and draws a conclusion based on the totality of the evidence, not only on a variation in the pupil size.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s1529-1839(04)70037-8 | DOI Listing |
Adv Sci (Weinh)
January 2025
State Key Laboratory for Chemo/Biosensing and Chemometrics, Advanced Catalytic Engineering Research Center of the Ministry of Education and College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, P. R. China.
The cobalt-nitrogen-carbon (Co─N─C) single-atom catalysts (SACs) are promising alternatives to precious metals for catalyzing the hydrogen evolution reaction (HER) and their activity is highly dependent on the coordination environments of the metal centers. Herein, a NaHCO etching strategy is developed to introduce abundant in-plane pores within the carbon substrates that further enable the construction of low-coordinated and asymmetric Co─N sites with nearby vacancy defects in a Co─N─C catalyst. This catalyst exhibits a high HER activity with an overpotential (η) of merely 78 mV to deliver a current density of 10 mA cm, a Tafel slope of 45.
View Article and Find Full Text PDFOncoimmunology
December 2025
Immunology Programme, Life Sciences Institute; Centre for Life Sciences, National University of Singapore, Singapore, Singapore.
Tumor-promoting inflammation significantly impacts cancer progression, and targeting inflammatory cytokines has emerged as a promising therapeutic approach in clinical trials. Interleukin (IL)-1α, a member of the IL-1 cytokine family, plays a crucial role in both inflammation and carcinogenesis. How IL-1α is secreted in the tumor microenvironment has been poorly understood, and we previously showed that calpain 1 cleaves pro-IL-1α for mature IL-1α secretion, which exacerbates hepatocellular carcinoma by recruiting myeloid-derived suppressor cells.
View Article and Find Full Text PDFJ Vis Exp
December 2024
Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University.
Evaluating the local immune microenvironment of the canine nasal cavity can be important for investigating normal tissue health and disease conditions, particularly those associated with local inflammation. We have optimized a technique to evaluate the local nasal immune microenvironment of dogs via serial nasal lavage. Briefly, with dogs under anesthesia and positioned in sternal recumbency, prewarmed sterile saline is flushed into the affected nostril using a flexible soft rubber catheter.
View Article and Find Full Text PDFAm J Cancer Res
December 2024
Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Chang Gung University Taoyuan 33305, Taiwan.
Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated cancer, and immune checkpoint inhibitors (ICIs) have shown efficacy in its treatment. The combination of chemotherapy and ICIs represents a new trend in the standard care for metastatic NPC. In this study, we aim to clarify the immune cell profile and related prognostic factors in the ICI-based treatment of metastatic NPC.
View Article and Find Full Text PDFAm J Cancer Res
December 2024
Laboratory of Translational Oncology and Experimental Cancer Therapeutics, The Warren Alpert Medical School, Brown University Providence, RI 02903, USA.
Androgen receptor (AR) signaling is a target in prostate cancer therapy and can be treated with non-steroidal anti-androgens (NSAA) including enzalutamide, and apalutamide for patients with advanced disease. Metastatic castration-resistant prostate cancer (mCPRC) develop resistance becomes refractory to therapy limiting patient overall survival. Darolutamide is a novel next-generation androgen receptor-signaling inhibitor that is FDA approved for non-metastatic castration resistant prostate cancer (nmCRPC).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!